IMPACT OF TISSUE-BASED GENOMIC TESTING ON PAYMENTS FOR PROSTATE CANCER CARE

被引：0
|
作者：
Croll, Benjamin
Patil, Dattatraya
Patel, Sagar
Filson, Christopher
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP17-04
引用
收藏
页码：E213 / E214
页数：2
相关论文
共 50 条
  • [1] Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer
    Leapman, Michael S.
    Sutherland, Ryan
    Gross, Cary P.
    Ma, Xiaomei
    Seibert, Tyler M.
    Cooperberg, Matthew R.
    Catalona, William J.
    Loeb, Stacy
    Schulman-Green, Dena
    BJUI COMPASS, 2024, 5 (01): : 142 - 149
  • [2] PATIENT AND GEOGRAPHIC FACTORS ASSOCIATED WITH EARLY ADOPTION OF TISSUE-BASED GENOMIC TESTING FOR PROSTATE CANCER
    Armas-Phan, Manuel
    Patil, Dattatraya
    Patel, Sagar
    Horny, Michal
    Filson, Christopher
    JOURNAL OF UROLOGY, 2023, 209 : E594 - E594
  • [3] Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.
    Leapman, Michael
    Sutherland, Ryan Andrew
    Gross, Cary Philip
    Ma, Xiaomei
    Jeong, Farah
    Seibert, Tyler M.
    Cooperberg, Matthew R.
    Catalona, William
    Loeb, Stacy
    Schulman-Green, Dena
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [4] Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer
    Ingrosso, Gianluca
    Ali, Emanuele
    Marani, Simona
    Saldi, Simonetta
    Bellavita, Rita
    Aristei, Cynthia
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [5] Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
    Marco Moschini
    Martin Spahn
    Agostino Mattei
    John Cheville
    R. Jeffrey Karnes
    BMC Medicine, 14
  • [6] Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
    Moschini, Marco
    Spahn, Martin
    Mattei, Agostino
    Cheville, John
    Karnes, R. Jeffrey
    BMC MEDICINE, 2016, 14
  • [7] Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer
    Ross, A. E.
    D'Amico, A. V.
    Freedland, S. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (01) : 1 - 6
  • [8] Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer
    A E Ross
    A V D'Amico
    S J Freedland
    Prostate Cancer and Prostatic Diseases, 2016, 19 : 1 - 6
  • [9] Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX
    Bologna, Eugenio
    Ditonno, Francesco
    Licari, Leslie Claire
    Franco, Antonio
    Manfredi, Celeste
    Mossack, Spencer
    Pandolfo, Savio Domenico
    De Nunzio, Cosimo
    Simone, Giuseppe
    Leonardo, Costantino
    Franco, Giorgio
    CLINICS AND PRACTICE, 2024, 14 (02) : 508 - 520
  • [10] Introduction to the Symposium on "Discovery and Development of Tissue-Based Biomarkers in Prostate Cancer"
    Knudsen, BS
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 : S6 - S6
12345